Rock Springs Capital Management LP
Filing Date
Global Rank
#1,089
/ 8,232
▲ 2
Top Industry
Biotechnology
73.7%
3Y Alpha vs SPY
-35.6%
Period ended 2 months ago
Filed May 15, 2026 · 30d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-38.2%
SPY
+76.3%
Annualised alpha
-35.6%
Max drawdown
−64.7%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
98 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
7.0%
+1.2 pts
Top 5
26.3%
+0.7 pts
Top 10
40.7%
−1.8 pts
HHI
258
Diversified−6
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,690,777,301 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| HTFL | Heartflow, Inc. | +294,800 | 572,500 | $13,928,925 | |
| ERAS | Erasca, Inc. | +151,759 | 1,103,469 | $17,854,128 | |
| BSX | Boston Scientific Corp | +116,250 | 515,300 | $32,335,075 | |
| PTCT | Ptc Therapeutics, Inc. | +99,919 | 161,798 | $11,023,297 | |
| EDAP | Edap Tms SA | +91,500 | 1,378,000 | $5,126,160 | |
| OLMA | Olema Pharmaceuticals, Inc. | +72,138 | 170,378 | $2,540,335 | |
| BCAX | Bicara Therapeutics Inc. | +60,000 | 489,095 | $9,728,099 | |
| DYN | Dyne Therapeutics, Inc. | +59,243 | 972,198 | $17,625,949 | |
| MIRM | Mirum Pharmaceuticals, Inc. | +49,000 | 811,294 | $74,947,339 | |
| ATEC | Alphatec Holdings, Inc. | +47,500 | 350,000 | $3,808,000 | |
| ALKS | Alkermes plc. | +44,758 | 183,986 | $6,505,744 | |
| OCUL | Ocular Therapeutix, Inc | +37,896 | 383,716 | $3,250,074 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | +31,381 | 170,999 | $89,512,846 | |
| ELVN | Enliven Therapeutics, Inc. | +28,095 | 826,500 | $32,398,800 | |
| CNTA | Centessa Pharmaceuticals plc | +27,813 | 351,828 | $13,974,608 | |
| IRTC | iRhythm Holdings, Inc. | +26,750 | 261,750 | $30,891,735 | |
| NBIX | Neurocrine Biosciences Inc | +24,950 | 150,450 | $19,820,283 | |
| BBIO | BridgeBio Pharma, Inc. | +24,750 | 128,250 | $9,523,845 | |
| PHVS | Pharvaris N.V. | +22,131 | 645,533 | $18,236,307 | |
| ACRS | Aclaris Therapeutics, Inc. | +18,909 | 4,472,650 | $16,772,437 | |
| PCVX | Vaxcyte, Inc. | +13,250 | 60,250 | $3,501,127 | |
| APLS | Apellis Pharmaceuticals, Inc. | +12,250 | 162,750 | $6,547,432 | |
| UNH | Unitedhealth Group Inc | +12,200 | 53,000 | $14,341,270 | |
| MLYS | Mineralys Therapeutics, Inc. | +12,155 | 439,751 | $11,912,854 | |
| SLNO | Soleno Therapeutics Inc | +10,200 | 257,253 | $8,612,830 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
23 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS, INC. | −1,908,869 | 21,062 | $304,556 | |
| GOSS | Gossamer Bio, Inc. | −1,657,468 | 1,609,492 | $529,522 | |
| TVTX | Travere Therapeutics, Inc. | −732,368 | 1,477,954 | $43,910,013 | |
| CMPX | Compass Therapeutics, Inc. | −621,894 | 3,305,308 | $17,485,079 | |
| PHR | Phreesia, Inc. | −276,200 | 600,400 | $5,031,352 | |
| COGT | Cogent Biosciences, Inc. | −224,875 | 624,155 | $24,023,725 | |
| OMDA | Omada Health, Inc. | −199,000 | 541,000 | $6,800,370 | |
| RVMD | Revolution Medicines, Inc. | −125,805 | 1,209,465 | $117,620,471 | |
| CAI | Caris Life Sciences, Inc. | −124,500 | 563,000 | $10,066,440 | |
| GPCR | Structure Therapeutics Inc. | −108,019 | 640,217 | $30,858,459 | |
| SGRY | Surgery Partners, Inc. | −102,000 | 208,000 | $2,479,360 | |
| VERA | Vera Therapeutics, Inc. | −64,994 | 503,585 | $20,259,224 | |
| EW | Edwards Lifesciences Corp | −53,600 | 28,900 | $2,314,312 | |
| RARE | Ultragenyx Pharmaceutical Inc. | −48,468 | 1,218,773 | $25,533,294 | |
| ACHC | Acadia Healthcare Company, Inc. | −44,500 | 75,500 | $1,765,945 | |
| CLDX | Celldex Therapeutics, Inc. | −42,268 | 650,270 | $20,626,564 | |
| TARS | Tarsus Pharmaceuticals, Inc. | −35,165 | 225,179 | $15,796,306 | |
| XENE | Xenon Pharmaceuticals Inc. | −24,768 | 763,020 | $44,369,613 | |
| ASND | Ascendis Pharma A/S | −9,500 | 194,000 | $44,373,620 | |
| LLY | ELI LILLY & Co | −6,700 | 98,700 | $90,781,299 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | −5,262 | 689,748 | $59,987,383 | |
| INSM | INSMED Inc | −4,950 | 314,300 | $51,394,336 | |
| ARGX | Argenx SE | −4,750 | 98,500 | $71,929,625 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| MMED | MiniMed Group, Inc. | 1,055,000 | $15,740,600 | |
| INDV | Indivior Pharmaceuticals, Inc. | 200,000 | $6,096,000 | |
| SYK | Stryker Corp | 14,800 | $4,863,132 | |
| NVO | Novo Nordisk A S | 90,000 | $3,307,500 | |
| VKTX | Viking Therapeutics, Inc. | 96,000 | $3,123,840 | |
| IPSC | Century Therapeutics, Inc. | 1,304,347 | $2,947,824 | |
| CVS | CVS HEALTH Corp | 40,000 | $2,872,800 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | 26,757 | $2,245,447 | |
| ORKA | Oruka Therapeutics, Inc. | 4,123 | $202,233 | |
| BCRX | Biocryst Pharmaceuticals Inc | 12,600 | $119,952 | |
| No positions match the current search. | ||||
98 positions ·
$1,690,777,301 total
· as of Mar 31, 2026
Showing 1–50
of 98 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 1,209,465 | $117,620,471 | 6.96% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 98,700 | $90,781,299 | 5.37% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
Added | 170,999 | $89,512,846 | 5.29% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Added | 811,294 | $74,947,339 | 4.43% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 98,500 | $71,929,625 | 4.25% | |
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
Reduced | 689,748 | $59,987,383 | 3.55% | |
| INSM |
INSMED Inc
Healthcare
|
Reduced | 314,300 | $51,394,336 | 3.04% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 194,000 | $44,373,620 | 2.62% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 763,020 | $44,369,613 | 2.62% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Reduced | 1,477,954 | $43,910,013 | 2.60% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Held | 496,871 | $41,384,385 | 2.45% | |
| PEN |
Penumbra Inc
Healthcare
|
Held | 120,500 | $39,568,585 | 2.34% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Held | 82,000 | $37,801,180 | 2.24% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Added | 739,816 | $36,369,354 | 2.15% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 826,500 | $32,398,800 | 1.92% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 515,300 | $32,335,075 | 1.91% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
Added | 261,750 | $30,891,735 | 1.83% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 640,217 | $30,858,459 | 1.83% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Held | 799,163 | $27,035,684 | 1.60% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Reduced | 1,218,773 | $25,533,294 | 1.51% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Added | 74,000 | $24,484,380 | 1.45% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 624,155 | $24,023,725 | 1.42% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
Held | 125,000 | $23,588,750 | 1.40% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 355,600 | $22,331,680 | 1.32% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 650,270 | $20,626,564 | 1.22% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 503,585 | $20,259,224 | 1.20% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Added | 150,450 | $19,820,283 | 1.17% | |
| ACLX |
Arcellx, Inc.
Healthcare
|
Held | 169,859 | $19,503,210 | 1.15% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Held | 588,794 | $18,847,295 | 1.11% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Added | 645,533 | $18,236,307 | 1.08% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 1,103,469 | $17,854,128 | 1.06% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 972,198 | $17,625,949 | 1.04% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 3,305,308 | $17,485,079 | 1.03% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Added | 4,472,650 | $16,772,437 | 0.99% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 225,179 | $15,796,306 | 0.93% | |
| MMED |
MiniMed Group, Inc.
Healthcare
|
NEW | 1,055,000 | $15,740,600 | 0.93% | |
| ZLAB |
Zai Lab Ltd
Healthcare
|
Added | 814,707 | $15,324,638 | 0.91% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 53,000 | $14,341,270 | 0.85% | |
| CNTA |
Centessa Pharmaceuticals plc
Healthcare
|
Added | 351,828 | $13,974,608 | 0.83% | |
| HTFL |
Heartflow, Inc.
Healthcare
|
Added | 572,500 | $13,928,925 | 0.82% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
Held | 2,299,473 | $13,773,843 | 0.81% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
Held | 710,000 | $13,461,600 | 0.80% | |
| AZTA |
Azenta, Inc.
Healthcare
|
Held | 569,100 | $12,025,083 | 0.71% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Added | 439,751 | $11,912,854 | 0.70% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Held | 61,500 | $11,660,400 | 0.69% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 161,798 | $11,023,297 | 0.65% | |
| CAI |
Caris Life Sciences, Inc.
Healthcare
|
Reduced | 563,000 | $10,066,440 | 0.60% | |
| ZBIO |
Zenas BioPharma, Inc.
Healthcare
|
Held | 502,077 | $9,815,605 | 0.58% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 489,095 | $9,728,099 | 0.58% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Added | 128,250 | $9,523,845 | 0.56% |